2022
DOI: 10.1111/jvim.16497
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease

Abstract: Background: Serum symmetric dimethylarginine (SDMA) concentrations are considered a biomarker for renal dysfunction in dogs and humans with acute kidney injury (AKI). No studies have assessed SDMA in cats with AKI.Hypothesis/Objectives: SDMA correctly identifies cats with azotemic AKI.Animals: Fifteen control cats, 22 with novel AKI, 13 with acute on chronic-AKI (AoC) and 19 with chronic kidney disease (CKD). Methods: Retrospective study. Cats with azotemia (serum creatinine concentrations >1.7 mg/dL) were def… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 53 publications
0
3
0
Order By: Relevance
“…Although diagnosis should never be limited to a single renal biomarker, aberrant sSDMA results because of delayed analysis might complicate the diagnosis and staging of CKD. The extent of these clinical errors in a subsample of animals with normal (<18 μg/dL) and increased sSDMA concentrations (≥18 μg/dL) 30,31 is summarized in Table 2.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Although diagnosis should never be limited to a single renal biomarker, aberrant sSDMA results because of delayed analysis might complicate the diagnosis and staging of CKD. The extent of these clinical errors in a subsample of animals with normal (<18 μg/dL) and increased sSDMA concentrations (≥18 μg/dL) 30,31 is summarized in Table 2.…”
Section: Resultsmentioning
confidence: 99%
“…Although diagnosis should never be limited to a single renal biomarker, aberrant sSDMA results because of delayed analysis might complicate the diagnosis and staging of CKD. The extent of these clinical errors in a subsample of animals with normal (<18 μg/dL) and increased sSDMA concentrations (≥18 μg/dL) 30,31 is summarized in Table 2. Age in years 6.5 ( F I G U R E 2 Visualization of the (pre-)analytical conditions that were subjected to a pairwise comparison of means and to an equivalence test (on the left side of the figure).…”
Section: Effect Of Preanalytical Storage Time and Temperature On Ssdm...mentioning
confidence: 99%
See 1 more Smart Citation
“…O biomarcador sérico Dimetilarginina simétrica (SDMA) é um aminoácido cujas elevações nas concentrações séricas indicam proteólise que é exclusivamente excretada pelos rins (Hall et al, 2014). Cerca de 90% de sua excreção é renal e o aumento das concentrações séricas podem indicar a redução na TFG (Loane et al, 2022). De acordo com Dahlem et al (2017), a molécula pode indicar tanto a LRA quanto a DRC; porém, não foi possível diferenciar o tipo de acometimento renal.…”
Section: Avaliação Laboratorial Do Paciente Crítico Com Lraunclassified
“…Hence, these biomarkers cannot predict the renal function based on their concentration before decompression [ 11 ]. In AKI in cats, however, SDMA is useful when there is a sedimented AKI [ 12 ]. In the face of these findings, it is believed that in feline UO, SDMA may work as a biomarker for the early detection of chronic kidney disease (CKD) cats in which an irreversible kidney injury has been established after a long time of UO.…”
Section: Introductionmentioning
confidence: 99%